Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 12/2017

01-12-2017 | Letter to the Editor

Vitamin D deficiency in systemic sclerosis: a possible role of subclinical liver fibrosis? Retrospective analysis from an Italian cohort

Authors: Francesco Ursini, Salvatore D’Angelo, Angela Padula, Pietro Leccese, Giuseppina Abignano, Gianna Angela Mennillo, Giorgio Ammerata, Giovambattista De Sarro, Ignazio Olivieri

Published in: Clinical Rheumatology | Issue 12/2017

Login to get access

Excerpt

Dear Sir, …
Literature
1.
Giuggioli D, Colaci M, Cassone G, Fallahi P, Lumetti F, Spinella A, Campomori F, Manfredi A, Manzini CU, Antonelli A, Ferri C (2017) Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature. Clin Rheumatol 36(3):583–590. doi:10.​1007/​s10067-016-3535-z CrossRefPubMed
2.
Caramaschi P, Dalla Gassa A, Ruzzenente O, Volpe A, Ravagnani V, Tinazzi I, Barausse G, Bambara LM, Biasi D (2010) Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol 29(12):1419–1425. doi:10.​1007/​s10067-010-1478-3 CrossRefPubMed
3.
Cruz-Dominguez MP, Garcia-Collinot G, Saavedra MA, Medina G, Carranza-Muleiro RA, Vera-Lastra OL, Jara LJ (2017) Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis. Clin Rheumatol 36(1):111–117. doi:10.​1007/​s10067-016-3412-9 CrossRefPubMed
4.
Abignano G, Cuomo G, Buch MH, Rosenberg WM, Valentini G, Emery P, Del Galdo F (2014) The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis. Ann Rheum dis 73(2):420–427. doi:10.​1136/​annrheumdis-2012-202843 CrossRefPubMed
5.
Lee SW, Kim BK, Park JY, Kim DY, Ahn SH, Song JJ, Park YB, Lee SK, Han KH, Kim SU (2015) Disease duration and Medsger’s severity score are associated with significant liver fibrosis in patients with systemic sclerosis. Clin Exp Rheumatol 33(4 Suppl 91):S68–S74PubMed
6.
Ursini F, D'Angelo S, Padula A, Gilio M, Russo E, Naty S, De Sarro G, Grembiale RD, Olivieri I (2016) Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: comment on “Reduced incidence of type 1 diabetes and type 2 diabetes in systemic sclerosis: a nationwide cohort study” by Tseng et al., joint bone spine 83:307–13. Joint Bone Spine 83(5):611–612. doi:10.​1016/​j.​jbspin.​2016.​07.​006 CrossRefPubMed
7.
8.
Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY (2011) Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 53(3):726–736. doi:10.​1002/​hep.​24105 CrossRefPubMed
Metadata
Title
Vitamin D deficiency in systemic sclerosis: a possible role of subclinical liver fibrosis? Retrospective analysis from an Italian cohort
Authors
Francesco Ursini
Salvatore D’Angelo
Angela Padula
Pietro Leccese
Giuseppina Abignano
Gianna Angela Mennillo
Giorgio Ammerata
Giovambattista De Sarro
Ignazio Olivieri
Publication date
01-12-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3709-3

Other articles of this Issue 12/2017

Clinical Rheumatology 12/2017 Go to the issue

Brief Report

Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus

Original Article

Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis

Original Article

To be or not to be rheumatologist: survey among Belgian medical students and internal medicine trainees: what do certified rheumatologists think about the current rheumatology training program?

Original Article

The therapeutic effect of probiotics on rheumatoid arthritis: a systematic review and meta-analysis of randomized control trials

Original Article

Diagnostic performances of serum IgG4 concentration and IgG4/IgG ratio in IgG4-related disease

Original Article

Effect of vitamin D supplementation in chronic widespread pain: a systematic review and meta-analysis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits